Adapt Pharma’s Narcan Nasal Spray now available in U.S.

DUBLIN — Adapt Pharma on Friday announced the availability of its Narcan (naloxone HCl) Nasal Spray — an emergency treatment for opioid overdose, and the only naloxone nasal spray in the United States, according to the company. 

 

The 4-mg nasal spray is available directly online or through such wholesalers as AmerisouceBergen, Cardinal Health, McKesson and HD Smith, as well as some specialty distributors. 

 

Adapt Pharma is offering a free carton of Narcan Nasal Spray to U.S. high schools through a partnership with the Clinton Foundation’s Clinton Health Matters Initiative and in collaboration with state education departments. Additionally, as the company previously announced, it is offering public interest pricing for local and state government agencies, school districts, higher education institutions and nonprofits for $75 per two-pack. 

 

“The U.S. is facing an unprecedented opioid overdose epidemic, and we are grateful for the opportunity to officially provide the communities on the frontline of this battle a ready-to-use, needle-free, effective emergency treatment,” Adapt Pharma chairman and CEO Seamus Mulligan said. “Opioid overdoses can occur anywhere and at any time. By making Narcan Nasal Spray available, we hope to increase everyone's access to emergency treatments across the U.S., when every second matters.”